ID
29016
Description
Study part: Serious Adverse Event Reporting. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Keywords
Versions (1)
- 2/20/18 2/20/18 -
Copyright Holder
Roche
Uploaded on
February 20, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Serious Adverse Event Reporting rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Serious Adverse Event Reporting
- StudyEvent: ODM
Description
Relevant Diagnostic Tests Performed (To diagnose or confirm primary SAE):
Alias
- UMLS CUI-1
- C0086143
Description
Diagnostic tests
Data type
boolean
Alias
- UMLS CUI [1]
- C0086143
Description
Diagnostic tests
Data type
text
Alias
- UMLS CUI [1]
- C0086143
Description
Date Performed
Data type
date
Alias
- UMLS CUI [1,1]
- C0430022
- UMLS CUI [1,2]
- C0011008
Description
test result
Data type
text
Alias
- UMLS CUI [1]
- C0456984
Description
test result
Data type
boolean
Alias
- UMLS CUI [1]
- C0456984
Description
• Associated signs and symptoms, if applicable • Clinical course (e.g. sequence of events) • Elaborate on suspected causes of SAE • Any specific treatment for the SAE
Data type
text
Alias
- UMLS CUI [1]
- C1546922
Similar models
Serious Adverse Event Reporting
- StudyEvent: ODM
C2986440 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C0877248 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
C0304229 (UMLS CUI-2)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0087111 (UMLS CUI [1,2])
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
(Comment:en)
C0011008 (UMLS CUI [1,2])